Arcutis Biotherapeutics (ARQT) Enterprise Value (2020 - 2025)
Historic Enterprise Value for Arcutis Biotherapeutics (ARQT) over the last 6 years, with Q3 2025 value amounting to -$191.1 million.
- Arcutis Biotherapeutics' Enterprise Value rose 4219.89% to -$191.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$191.1 million, marking a year-over-year increase of 4219.89%. This contributed to the annual value of -$228.0 million for FY2024, which is 1615.02% up from last year.
- According to the latest figures from Q3 2025, Arcutis Biotherapeutics' Enterprise Value is -$191.1 million, which was up 4219.89% from -$190.8 million recorded in Q2 2025.
- In the past 5 years, Arcutis Biotherapeutics' Enterprise Value registered a high of -$190.8 million during Q2 2025, and its lowest value of -$477.0 million during Q3 2022.
- Its 5-year average for Enterprise Value is -$322.4 million, with a median of -$332.4 million in 2023.
- As far as peak fluctuations go, Arcutis Biotherapeutics' Enterprise Value plummeted by 9359.34% in 2021, and later surged by 5238.35% in 2023.
- Over the past 5 years, Arcutis Biotherapeutics' Enterprise Value (Quarter) stood at -$387.1 million in 2021, then decreased by 5.82% to -$409.6 million in 2022, then soared by 33.63% to -$271.9 million in 2023, then increased by 16.15% to -$228.0 million in 2024, then rose by 16.18% to -$191.1 million in 2025.
- Its Enterprise Value stands at -$191.1 million for Q3 2025, versus -$190.8 million for Q2 2025 and -$198.1 million for Q1 2025.